KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Total Debt: 2017-2020

Historic Total Debt for Xenon Pharmaceuticals (XENE) over the last 2 years, with Mar 2020 value amounting to $15.7 million.

  • Xenon Pharmaceuticals' Total Debt rose 3.55% to $15.7 million in Q1 2020 from the same period last year, while for Mar 2020 it was $15.7 million, marking a year-over-year increase of 3.55%. This contributed to the annual value of $15.5 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q1 2020, Xenon Pharmaceuticals' Total Debt is $15.7 million, which was up 0.88% from $15.5 million recorded in Q4 2019.
  • In the past 5 years, Xenon Pharmaceuticals' Total Debt ranged from a high of $15.7 million in Q1 2020 and a low of $6.8 million during Q4 2017.
  • Over the past 3 years, Xenon Pharmaceuticals' median Total Debt value was $15.2 million (recorded in 2019), while the average stood at $13.8 million.
  • Data for Xenon Pharmaceuticals' Total Debt shows a peak YoY surged of 120.17% (in 2019) over the last 5 years.
  • Xenon Pharmaceuticals' Total Debt (Quarterly) stood at $6.8 million in 2017, then reached $14.9 million in 2018, then rose by 3.47% to $15.5 million in 2019, then rose by 3.55% to $15.7 million in 2020.
  • Its Total Debt was $15.7 million in Q1 2020, compared to $15.5 million in Q4 2019 and $15.4 million in Q3 2019.